Variant report
Variant | nsv963561 |
---|---|
Chromosome Location | chr3:24990649-24993786 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:24984996..24987861-chr3:24992367..24994337,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554893434 | chr3:24990669-24990670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192993129 | chr3:24990678-24990679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116287336 | chr3:24990680-24990681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184802483 | chr3:24990687-24990688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530144128 | chr3:24990693-24990694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188108332 | chr3:24990731-24990732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191831420 | chr3:24990739-24990740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532781326 | chr3:24990743-24990744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552887353 | chr3:24990797-24990798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566266909 | chr3:24990814-24990815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533735768 | chr3:24990817-24990818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112856884 | chr3:24990823-24990824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551160351 | chr3:24990826-24990827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147440495 | chr3:24990833-24990834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535941001 | chr3:24990877-24990878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555870621 | chr3:24990881-24990882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76339855 | chr3:24990883-24990884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544822805 | chr3:24990886-24990887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183675325 | chr3:24990908-24990909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544629166 | chr3:24990909-24990910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188333039 | chr3:24990926-24990927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564781816 | chr3:24990932-24990933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550945316 | chr3:24990959-24990960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192499177 | chr3:24990970-24990971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533397874 | chr3:24990976-24990977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540788325 | chr3:24990977-24990978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560592344 | chr3:24990993-24990994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368522195 | chr3:24990996-24990997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376341240 | chr3:24991032-24991033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs60632616 | chr3:24991053-24991054 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs78535493 | chr3:24991077-24991078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550944399 | chr3:24991079-24991080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139641878 | chr3:24991081-24991082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185747314 | chr3:24991091-24991092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528772263 | chr3:24991094-24991095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116085474 | chr3:24991097-24991098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143654825 | chr3:24991111-24991112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535880868 | chr3:24991159-24991160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147263363 | chr3:24991178-24991179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569432170 | chr3:24991211-24991212 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148747020 | chr3:24991214-24991215 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17195094 | chr3:24991227-24991228 | Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs115297239 | chr3:24991274-24991275 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2362765 | chr3:24991305-24991306 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554875363 | chr3:24991334-24991335 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs199782298 | chr3:24991362-24991363 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76146988 | chr3:24991371-24991372 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372967516 | chr3:24991386-24991387 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376789714 | chr3:24991395-24991396 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543853021 | chr3:24991453-24991454 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24979200-24998400 | Weak transcription | Right Atrium | heart |
2 | chr3:24987000-24996800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr3:24991200-24991400 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr3:24991400-24991600 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
5 | chr3:24992600-24993000 | Enhancers | Brain Inferior Temporal Lobe | brain |
6 | chr3:24992800-24993000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr3:24992800-24993400 | Enhancers | Brain Substantia Nigra | brain |
8 | chr3:24993400-24994200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr3:24993600-24995000 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |